EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SRSF3 plays a key role in liver cancer sex disparity by facilitating hepatocyte expression of ERα and FOXA

Lulu Yu iD, Masahiko Ajiro, Vladimir Majerciak iD, Alexei Lobanov, Yafeng He, Maggie Cam, Baktiar Karim iD, Deanna Gotte iD, Chuxia Deng, Keji Zhao iD, Douglas R Lowy, Nicholas J G Webster und 1 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2536317123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Lulu Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD 2170…. Hauptthemen laut MEDLINE: Estrogen Receptor alpha, Hepatocytes, Serine-Arginine Splicing Factors, Hepatocyte Nuclear Factor 3-alpha. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, HHS | NIH | National Cancer Institute (NCI), HHS | NIH | NCI | Center for Cancer Research (CCR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SRSF3 (SRp20) is an essential RNA splicing factor. By conditional knockout (KO) of Srsf3, we found Srsf3 at its physiological level plays a tumor-suppressive role in mouse liver carcinogenesis. Srsf3 KO in hepatocytes disrupted sex disparity in the development of DEN-induced liver cancer and resulted in high incidence of liver cancer in both male and female mice. In contrast, Srsf3 is oncogenic in the mouse mammary glands and Srsf3 KO significantly delayed the development of Erbb2 breast cancer. Srsf3 KO significantly increased the expression of transcription factors Sox4, E2f1, and Myc, calcium channel factor Trpv4, and zinc-binding Trim6 in liver cancer, but did not in Erbb2 breast cancer. Srsf3 KO enhanced the expression of glucose transmembrane transporter Mfsd4a and translation initiator Eif4a2 in DEN-induced liver cancer but reduced Mfsd4a and Eif4a2 expression in breast cancer. More importantly, Srsf3 KO reduced the expression of hepatocyte ERα and transcription factor Foxa family genes essential for sexual dimorphism in liver cancer and their downstream targets leukemia inhibitory factor receptor Lifr and epidermal growth factor receptor Egfr, but increased the expression of Myc. We further evidenced that SRSF3 binds to FOXA1 promoter and is responsible for FOXA1 promoter activity and FOXA1 expression in liver cancer cells. Together, our data highlight a functional paradigm of SRSF3 at its physiological level in tissue context-dependent gene regulation and in facilitating hepatocyte ERα and FOXA1 expression for sex disparity in liver cancer development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Estrogen Receptor alphaHepatocytesSerine-Arginine Splicing FactorsHepatocyte Nuclear Factor 3-alphaLiver NeoplasmsAnimalsFemaleMaleMiceMice, KnockoutGene Expression Regulation, NeoplasticHumansSex Characteristics

Stichwörter der Autor:innen

RNA splicingSRSF3breast cancergender disparityliver cancer

Substanzen

Estrogen Receptor alphaSerine-Arginine Splicing FactorsSrsf3 protein, mouseHepatocyte Nuclear Factor 3-alphaEsr1 protein, mouseFoxa1 protein, mouse

Autor:innen und Institutionen

  • Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD 21702.
  • Center for Cancer Research Collaborative Bioinformatics Resource, National Cancer Institute, NIH, Bethesda, MD 20892.
  • Laboratory of Epigenome Biology, Systems Biology Center, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.
  • Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
  • Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen 518107, China.
  • Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892.

ORCID-Profile: Lulu Yu, Vladimir Majerciak, Baktiar Karim, Deanna Gotte, Keji Zhao, Zhi-Ming Zheng

Förderung

  • Intramural NIH HHS
  • HHS | NIH | National Cancer Institute (NCI)
  • HHS | NIH | NCI | Center for Cancer Research (CCR)

Zitieren

APA

Yu, L., Ajiro, M., Majerciak, V., Lobanov, A., He, Y., Cam, M., Karim, B., Gotte, D., Deng, C., Zhao, K., Lowy, D. R., Webster, N. J. G., & Zheng, Z. M. (2026). SRSF3 plays a key role in liver cancer sex disparity by facilitating hepatocyte expression of ERα and FOXA. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2536317123

Vancouver

Yu L, Ajiro M, Majerciak V, Lobanov A, He Y, Cam M, et al. SRSF3 plays a key role in liver cancer sex disparity by facilitating hepatocyte expression of ERα and FOXA. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2536317123

BibTeX
@article{Yu2026,
  author = {Yu, Lulu and Ajiro, Masahiko and Majerciak, Vladimir and Lobanov, Alexei and He, Yafeng and Cam, Maggie and Karim, Baktiar and Gotte, Deanna and Deng, Chuxia and Zhao, Keji and Lowy, Douglas R and Webster, Nicholas J G and Zheng, Zhi-Ming},
  title = {SRSF3 plays a key role in liver cancer sex disparity by facilitating hepatocyte expression of ERα and FOXA},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2536317123}
}
Kostenlos starten →